405 related articles for article (PubMed ID: 9398405)
1. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
2. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
3. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
4. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
Stohl W; Elliott JE; Lynch DH; Kiener PA
J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions.
Miyashita T; McIlraith MJ; Grammer AC; Miura Y; Attrep JF; Shimaoka Y; Lipsky PE
J Immunol; 1997 May; 158(10):4620-33. PubMed ID: 9144474
[TBL] [Abstract][Full Text] [Related]
6. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
[TBL] [Abstract][Full Text] [Related]
7. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
Hirohata S; Lipsky PE
J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
[TBL] [Abstract][Full Text] [Related]
8. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.
Hirohata S; Jelinek DF; Lipsky PE
J Immunol; 1988 Jun; 140(11):3736-44. PubMed ID: 2967324
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
[TBL] [Abstract][Full Text] [Related]
11. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional modulation of human B cell stimulation by activated T cells.
Hirohata S; Shinohara S
Cell Immunol; 1993 Sep; 150(2):257-68. PubMed ID: 8370072
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of B cell expression of DNA polymerase alpha by CD4+ suppressor T cells.
Hirohata S
Cell Immunol; 1993 Aug; 150(1):159-67. PubMed ID: 8102086
[TBL] [Abstract][Full Text] [Related]
14. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
Noble A; Pestano GA; Cantor H
J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
[TBL] [Abstract][Full Text] [Related]
15. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
16. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
Desbarats J; Duke RC; Newell MK
Nat Med; 1998 Dec; 4(12):1377-82. PubMed ID: 9846574
[TBL] [Abstract][Full Text] [Related]
17. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
Stohl W; Lynch DH; Starling GC; Kiener PA
J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
[TBL] [Abstract][Full Text] [Related]
18. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548
[TBL] [Abstract][Full Text] [Related]
19. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
